General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Astra Zeneca(SIGNIFICANT), Boerhinger Ingelheim(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), CRISPR Therapeutics(MODEST), Merck & Co., Inc.(MODEST), Eli Lilly and Company(SIGNIFICANT), Esperion (SIGNIFICANT), Bayer Healthcare Pharmaceuticals(MODEST), Amgen(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Miga Health(SIGNIFICANT) OFFICER, DIRECTOR ETC: Physician Partners LLC(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Freedom Health, Inc(SIGNIFICANT), RXAdvance, LLC(SIGNIFICANT), Florida Medical Associates, LLC(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen(NONE), Boerhinger Ingelheim(NONE), Novo Nordisk Inc.(SIGNIFICANT), Eli Lilly and Company(MODEST), Novartis Corporation(NONE), Eggland's Best(NONE), Alnylam(NONE), Merck & Co., Inc.(NONE)

View Full Disclosure